Debate Round Table

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Paris–Robert Debré experience

C Acquaviva
M Duval
H Cavé
Debate Round Table03 Jan 2003
Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical–biological situations

Thomas Lion
Nicole Muller-Bérat
Debate Round Table31 Jul 2002
Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the Duet™ (BioView) combined morphological and cytogenetical analysis

Debate Round Table31 Jul 2002
Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet™) combined morphological and cytogenetical analysis

A Shimoni
A Nagler
L Trakhtenbrot
Debate Round Table31 Jul 2002
Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

JA Pérez-Simón
D Caballero
JF San Miguel
Debate Round Table31 Jul 2002
Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical–biological situations

Thomas Lion
Nicole Muller-Bérat
Debate Round Table29 Nov 2001
Current recommendations for positive controls in RT-PCR assays

T Lion
Debate Round Table19 Jul 2001
Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for chimerism testing in different clinical–biological situations

Thomas Lion
Nicole Muller-Bérat
Debate Round Table02 Dec 1999
Primary non-Hodgkin’s lymphoma of bone: a clinicopathological investigation of 60 cases

FH Heyning
PCW Hogendoorn
Ph M Kluin
Debate Round Table02 Dec 1999
Analysis of p73 and p53 gene deletions in multiple myeloma

B Schultheis
A Krämer
R Hehlmann
Debate Round Table02 Dec 1999
Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection

J Dubovsky
H Daxberger
T Lion
Debate Round Table02 Dec 1999
Transplantation of highly purified peripheral blood CD34⁺ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment

C Peters
S Matthes-Martin
H Gadner
Debate Round Table02 Dec 1999
Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children

P Bader
T Klingebiel
JF Beck
Debate Round Table02 Dec 1999
c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin’s lymphomas

L Hernández
S Hernández
E Campo
Debate Round Table02 Dec 1999
Editorial

JP Marie
Debate Round Table01 Jul 1997
Immunocytochemical detection of the multidrug resistance-associated protein and P-glycoprotein in acute myeloid leukemia: impact of antibodies, sample source and disease status

M Filipits
RW Suchomel
R Pirker
Debate Round Table01 Jul 1997
French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours

S Chevillard
Ph Vielh
J Robert
Debate Round Table01 Jul 1997
Apoptosis and resistance to daunorubicin in human leukemic cells

T Efferth
U Fabry
R Osieka
Debate Round Table01 Jul 1997
Methods to detect P-glycoprotein and implications for other drug resistance-associated proteins

WT Beck
TM Grogan
Debate Round Table01 Jul 1997
Multidrug resistance in acute leukemia: a comparison of different diagnostic methods

G Pall
M Spitaler
C Ludescher
Debate Round Table01 Jul 1997

Search

Advanced search

Debate Round Table

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Paris–Robert Debré experience

Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical–biological situations

Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the Duet™ (BioView) combined morphological and cytogenetical analysis

Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet™) combined morphological and cytogenetical analysis

Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical–biological situations

Current recommendations for positive controls in RT-PCR assays

Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for chimerism testing in different clinical–biological situations

Primary non-Hodgkin’s lymphoma of bone: a clinicopathological investigation of 60 cases

Analysis of p73 and p53 gene deletions in multiple myeloma

Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection

Transplantation of highly purified peripheral blood CD34⁺ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment

Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children

c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin’s lymphomas

Editorial

Immunocytochemical detection of the multidrug resistance-associated protein and P-glycoprotein in acute myeloid leukemia: impact of antibodies, sample source and disease status

French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours

Apoptosis and resistance to daunorubicin in human leukemic cells

Methods to detect P-glycoprotein and implications for other drug resistance-associated proteins

Multidrug resistance in acute leukemia: a comparison of different diagnostic methods

Search

Quick links

Debate Round Table

Filter By:

Search

Quick links